Blogs about: Taxotere
Featured Blog
ASCENT-2 Novacea Study Halted
Novacea, Inc. (NASDAQ: NOVC) announced on 11/5/07 that the company has ended its Phase 3 ASCENT-2 clinical trial of Asentar(TM) (DN-101), the company’s lead investigational cancer therapy for th… more »
Center for Oncology Research & Treatment--Dallas, TX
Herceptin
aklaura wrote 2 months ago: Well as the fun continues :D I started Herceptin yesterday, I have only 13 more to go… I d … more »
ASCENT-2 Novacea Study Halted
bmirtsching wrote 6 months ago: Novacea, Inc. (NASDAQ: NOVC) announced on 11/5/07 that the company has ended its Phase 3 ASCENT-2 cl … more »
Vectibix and Chemotherapy, E7389 (Eribulin) for Treatment of Head & Neck Cancer
bmirtsching wrote 7 months ago: Advances in the management of patients with head & neck cancer (HNC) were presented at the Mult … more »
FDA Approves Docetaxel (Taxotere) for Induction Chemotherapy in Head & Neck Cancer
bmirtsching wrote 7 months ago: On September 28, 2007, the U. S. Food and Drug Administration (FDA) approved docetaxel (Taxotere® I … more »
Combining Chemotherapy with Initial Hormone Therapy for Metastatic Prostate Cancer
bmirtsching wrote 7 months ago: Androgen ablation hormonal therapy (castration or LHRH drugs to reduce androgen levels) are the stan … more »
XRP6258 for Hormone-Refractory Prostate Cancer
bmirtsching wrote 7 months ago: XRP6258 is a novel taxane that has been shown to be active in patients with hormone refractory prost … more »
DN-101 (Ascentar) for Hormone-Refractory Prostate Cancer
bmirtsching wrote 7 months ago: DN-101 (Ascentar) is a high-dose formulation of the active form of vitamin D. Vitamin D, once though … more »
G-VAX Vaccine Study for Hormone-Refractory Prostate Cancer
bmirtsching wrote 7 months ago: G-VAX is a cellular vaccine against prostate cancer. Initial studies have demonstrated activity of G … more »
Have your say. Start a blog.
See our free features »
Copyright 2008 Automattic, Inc.
An 
Thingamajig
